Indonesian Political, Business & Finance News

UBSI’s International Collaboration Discusses AI and Supercomputers for Drug Development Research

| | Source: Republika Translated from Indonesian | Technology
UBSI’s International Collaboration Discusses AI and Supercomputers for Drug Development Research
Image: Republika

BEKASI — Artificial intelligence (AI) and high-performance computing technology are opening up new opportunities for research into natural products for drug development. However, their use must also take into account the security and confidentiality of research data. These issues were discussed at the International Visiting Research event organised by Universitas Bina Sarana Informatika (UBSI) at BSI Convention Center Hall C in Bekasi on Tuesday, 10 November 2026.

The event, themed “Artificial Intelligence and Privacy Computing for Natural Products Drug Screening”, brought together academics, researchers and students with international experts to discuss the use of AI and privacy computing in screening natural products as part of drug development research.

UBSI organised the event in collaboration with the National Research and Innovation Agency (BRIN), the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS), Singapore’s Nanyang Technological University (NTU), and Aptikom. The cross-institutional collaboration provided a forum for exchanging knowledge and an opportunity to expand research networks in technology and health.

The programme began with participant registration and a performance of the Merak dance, introducing guests to local culture. The event was then formally opened, followed by the singing of Indonesia Raya, the national anthem.

UBSI Vice-Rector I for Academic Affairs, Associate Professor Dr Diah Puspitasari, highlighted the importance of international collaboration and advanced technology in addressing challenges in healthcare. She said technological progress needed to be accompanied by stronger research partnerships so that the benefits of scientific advances could reach a wider public.

The next address was delivered by Professor Dr Didi Rosiyadi, representing BRIN. He stressed the importance of applying AI and privacy computing to the processing of natural-product research data, particularly to support compound screening while safeguarding the security and confidentiality of research information.

The main session was moderated by Associate Professor Dr Agus Priadi. Two international experts spoke: Professor Yanjie Wei, Director of High Performance Computing (HPC) at SIAT, Chinese Academy of Sciences, and Associate Professor Weihui Xi of Nanyang Technological University, Singapore.

The speakers discussed how AI and supercomputers can support natural-product screening in drug development research. High-performance computing enables researchers to process and analyse large-scale datasets, while privacy-preserving computing is an important consideration when research involves information that must be protected.

The discussion included an interactive question-and-answer session. UBSI academics, researchers and students used the opportunity to speak directly with the panellists about developments in computing technology and its application in interdisciplinary research.

Dr Diah said the event was part of UBSI’s efforts to broaden research collaboration and connect technological advances with healthcare research needs.

“Through this International Visiting Research programme, UBSI remains committed to facilitating the integration of advanced AI technology with the measured use of natural resources. We believe collaboration with SIAT CAS, NTU Singapore and BRIN will not only broaden the academic community’s horizons, but also generate research with a tangible impact in health and computing-based pharmaceutical technology worldwide,” Dr Diah said on Wednesday, 11 November.

UBSI, which describes itself as a Creative Digital Campus, hopes the meeting will mark the beginning of further collaboration and research with international partners, particularly in the use of AI, high-performance computing and data-protection technology to support natural-product research.

Through its International Visiting Research programme, UBSI aims to strengthen links between universities, research institutions and the international academic community. The collaboration is expected to go beyond an exchange of ideas and create opportunities for joint research addressing the needs of science, technology and health.

More from 12 November 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/ubsis-international-collaboration-discusses-ai-and-supercomputers-for-drug-development-research-1794469953)
Originally published by Republika (https://news.republika.co.id/berita/todl0h490/kolaborasi-internasional-ubsi-bahas-pemanfaatan-ai-dan-superkomputer-untuk-riset-pengembangan-obat), translated from Indonesian
Print